International Society of Liquid Biopsy shared a post on X:
“Liquid Biopsy Highlights from SABCS 2024.
Key insights on ctDNA and MRD in breast cancer:
- MRD Monitoring: Early detection of recurrence with ctDNA (ZEST, SURMOUNT, ALIENOR).
- Predictive Biomarkers: ctDNA-driven therapy guidance (PIK3CA, ESR1, AKT pathways).
- Response Evaluation: Dynamic changes in ctDNA correlate with treatment efficacy.”
“Cancer in a drop: Liquid biopsy highlights from San Antonio Breast Cancer Symposium (SABCS) 2024”
Authors: Letizia Pontolillo, Mohamed Gouda, Konstantinos Venetis, Eleonora Nicolò, Carolina Reduzzi.
More posts featuring International Society of Liquid Biopsy.
